Αποτελέσματα Αναζήτησης
25 Μαΐ 2023 · The following examples show overall survival rates for people with different types of cancer, along with the percentage of those receiving chemotherapy as part of their treatment.
23 Ιουν 2022 · Testicular cancer survival has increased from 83% in patients who were diagnosed during the mid-1970s to 95% in the most recent time period, largely because of the success of chemotherapy regimens for advanced disease.
7 Αυγ 2019 · Abstract. Adults aged 85 years and older, the “oldest old,” are the fastest-growing age group in the United States, yet relatively little is known about their cancer burden.
11 Ιουν 2019 · The majority of thyroid cancer survivors are women (78%), reflecting that the incidence in women is more than double that in men. 1 The median age at diagnosis—55 years for males and 50 years for females—is younger than that for most other adult cancers. 7
15 Ιαν 2010 · Even if induction is successful, no consolidation regimen (including high-dose cytarabine) has been shown to confer a survival advantage in AML patients over age 60. Attempts to treat older patients with less toxic regimens have produced some favorable responses, but no survival advantage.
Nearly two-thirds (64%) of survivors are 65 years of age or older, while only 1 in 10 are younger than 50 years of age (Table 2), with considerable variation by cancer type (Figure 2). Table 1. Estimated Number of US Cancer Survivors by Sex and Years Since Diagnosis as of January 1, 2019. Male and Female.
23 Νοε 2021 · Based on the overall cohort, that included 905 chemotherapy-exposed vs 3390 chemotherapy-naïve patients, overall survival rates at 18 and 30 months were 76.3 vs 69.3% and 61.6 vs 54.3%, favoring chemotherapy-exposed patients (Figure 1A).
